ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (22)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sim, D.
Right arrow Articles by Freezer, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sim, D.
Right arrow Articles by Freezer, N.
Eur Respir J 2003; 21:633-636
Copyright ©ERS Journals Ltd 2003


Adrenal suppression from high-dose inhaled fluticasone propionate in children with asthma

D. Sim1, A. Griffiths1, D. Armstrong1, C. Clarke2, C. Rodda2 and N. Freezer1,3

Depts of 1 Respiratory and Sleep Medicine and 2 Paediatric Endocrinology, Monash Medical Centre and 3 Centre for Heart and Chest Research, Monash University, Melbourne, Australia

CORRESPONDENCE: N. Freezer, Respiratory and Sleep Medicine, Monash Medical Centre, Melbourne, Australia. Fax: 61 395946415. E-mail: n.freezer@southernhealth.org.au

Keywords: adrenal suppression, asthma, children, flixotide

Received: January 3, 2002
Accepted May 25, 2002

This cross-sectional study was designed to examine the prevalence of adrenocortical suppression in children with asthma treated with high-dose inhaled fluticasone propionate (FP).

Children and adolescents (n=50) with asthma, treated with inhaled FP at a dose of ≥1,000 mg a day for ≥6 months, were enrolled. Early morning serum cortisol was performed. Subjects with a serum cortisol of <400 nmol·L–1 had a tetracosactrin stimulation test.

Fifty subjects of mean age 13.1 yrs were treated with a mean dose of 924.7 µg·m–2·day–1 FP for a mean duration of 2 yrs. Of the 50 subjects, 36 (72%) had serum cortisol levels of <400 nmol·L–1 and underwent tetracosactrin stimulation test. Of these, 6 (17%) demonstrated a less than two-fold increase in serum cortisol from baseline and peak cortisol level of ≤550 nmol·L–1 at 30 or 60 min poststimulation. There was a significant negative correlation between the dose of FP·m–2 and stimulated peak cortisol level.

Biochemical evidence of adrenocortical insufficiency was demonstrated in 12% of the subjects, indicating that high-dose fluticasone propionate use may be associated with dose-dependent adrenocortical suppression.




This article has been cited by other articles:


Home page
Arch. Dis. Child.Home page
S Turner, M Thomas, J von Ziegenweidt, and D Price
Prescribing trends in asthma: a longitudinal observational study
Arch. Dis. Child., January 1, 2009; 94(1): 16 - 22.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
J Paton, E Jardine, E McNeill, S Beaton, P Galloway, D Young, and M Donaldson
Adrenal responses to low dose synthetic ACTH (Synacthen) in children receiving high dose inhaled fluticasone
Arch. Dis. Child., October 1, 2006; 91(10): 808 - 813.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
D R Woods, C S Arun, P A Corris, and P Perros
Cushing's syndrome without excess cortisol.
BMJ, February 25, 2006; 332(7539): 469 - 470.
[Full Text] [PDF]


Home page
Eur Respir JHome page
K. N. Priftis, A. Papadimitriou, E. Gatsopoulou, P. K. Yiallouros, A. Fretzayas, and P. Nicolaidou
The effect of inhaled budesonide on adrenal and growth suppression in asthmatic children
Eur. Respir. J., February 1, 2006; 27(2): 316 - 320.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
S. Saglani, A. G. Nicholson, M. Scallan, I. Balfour-Lynn, M. Rosenthal, D. N. Payne, and A. Bush
Investigation of young children with severe recurrent wheeze: any clinical benefit?
Eur. Respir. J., January 1, 2006; 27(1): 29 - 35.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
A. E. Tattersfield, T. W. Harrison, R. B. Hubbard, and K. Mortimer
Safety of Inhaled Corticosteroids
Proceedings of the ATS, November 1, 2004; 1(3): 171 - 175.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
P Mahachoklertwattana, K Sudkronrayudh, C Direkwattanachai, L Choubtum, and C Okascharoen
Decreased cortisol response to insulin induced hypoglycaemia in asthmatics treated with inhaled fluticasone propionate
Arch. Dis. Child., November 1, 2004; 89(11): 1055 - 1058.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
M.J. Visser, E. van der Veer, D.S. Postma, L.R. Arends, T.W. de Vries, P.L.P. Brand, and E.J. Duiverman
Side-effects of fluticasone in asthmatic children: no effects after dose reduction
Eur. Respir. J., September 1, 2004; 24(3): 420 - 425.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
A. Mohn, M. Verini, R. Mele, C. De Leonardis, and F. Chiarelli
Adrenal suppression from high-dose inhaled fluticasone propionate in children with asthma
Eur. Respir. J., February 1, 2004; 23(2): 354 - 355.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the European Respiratory Society.